30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Pushkal Garg

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 52% 68% 82%
Transactions
123 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President - Clinical Development, Chief Medical Officer Alnylam Pharmaceuticals Inc Jan. 3, 2017 - Jan. 1, 2018
Senior Vice President - Clinical Development Alnylam Pharmaceuticals Inc None -
Pushkal Garg's trades of Alnylam Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-06 2026-03-05
PlS Planned sale
71,603 -15.9%
61.70
US$4,495,008 		71,603 -15.9% 61.70 US$4,495,008
2026-03-06 2026-03-05
PlS Planned sale
90,986 -1.6%
176.88
US$1,850,427 		90,986 -1.6% 176.88 US$1,850,427
2026-03-06 2026-03-05
PlS Planned sale
34,747 -36.6%
11.23
US$4,971,153 		34,747 -36.6% 11.23 US$4,971,153
2026-03-06 2026-03-05
PlS Planned sale
654 -3.1%
322.33
US$210,804 		654 -3.1% 322.33 US$210,804
2026-03-05 2026-03-05
PrS Proposed sale
2,404
323.69
US$778,151 		2,404 323.69 US$778,151
2026-03-06 2026-03-04
S Sale
208 -1.0%
325.67
US$67,739 		208 -1.0% 325.67 US$67,739
2026-03-06 2026-03-04
S Sale
272 -1.3%
324.88
US$88,367 		272 -1.3% 324.88 US$88,367
2026-03-06 2026-03-04
S Sale
767 -3.4%
323.84
US$248,385 		767 -3.4% 323.84 US$248,385
2026-03-06 2026-03-04
S Sale
350 -1.5%
323.01
US$113,054 		350 -1.5% 323.01 US$113,054
2026-03-06 2026-03-04
S Sale
289 -1.3%
321.82
US$93,006 		289 -1.3% 321.82 US$93,006
2026-03-06 2026-03-04
S Sale
215 -0.9%
320.81
US$68,974 		215 -0.9% 320.81 US$68,974
2026-03-06 2026-03-04
S Sale
102 -0.4%
320.01
US$32,641 		102 -0.4% 320.01 US$32,641
2026-03-06 2026-03-04
S Sale
106 -0.5%
319.03
US$33,817 		106 -0.5% 319.03 US$33,817
2026-03-04 2026-03-03
PlS Planned sale
463 -1.9%
321.50
US$148,854 		463 -1.9% 321.50 US$148,854
2026-03-04 2026-03-03
PlS Planned sale
640 -2.6%
320.48
US$205,107 		640 -2.6% 320.48 US$205,107
2026-03-04 2026-03-03
PlS Planned sale
317 -1.3%
319.06
US$101,142 		317 -1.3% 319.06 US$101,142
2026-03-04 2026-03-03
PlS Planned sale
355 -1.4%
316.74
US$112,443 		355 -1.4% 316.74 US$112,443
2026-03-03 2026-03-03
PrS Proposed sale
1,775
321.37
US$570,432 		1,775 321.37 US$570,432
2026-03-04 2026-03-02
S Sale
42 -0.2%
332.64
US$13,971 		42 -0.2% 332.64 US$13,971
2026-03-04 2026-03-02
S Sale
101 -0.4%
331.93
US$33,525 		101 -0.4% 331.93 US$33,525
2026-03-04 2026-03-02
S Sale
87 -0.3%
330.85
US$28,784 		87 -0.3% 330.85 US$28,784
2026-03-04 2026-03-02
S Sale
182 -0.7%
329.71
US$60,007 		182 -0.7% 329.71 US$60,007
2026-03-04 2026-03-02
S Sale
107 -0.4%
328.71
US$35,172 		107 -0.4% 328.71 US$35,172
2026-03-04 2026-03-02
S Sale
353 -1.4%
327.67
US$115,668 		353 -1.4% 327.67 US$115,668
2026-03-04 2026-03-02
S Sale
421 -1.6%
326.81
US$137,587 		421 -1.6% 326.81 US$137,587
2026-03-04 2026-03-02
S Sale
277 -1.0%
325.63
US$90,200 		277 -1.0% 325.63 US$90,200
2026-03-04 2026-03-02
S Sale
97 -0.4%
324.65
US$31,491 		97 -0.4% 324.65 US$31,491
2026-03-04 2026-03-02
S Sale
50 -0.2%
323.62
US$16,181 		50 -0.2% 323.62 US$16,181
2026-03-02 2026-02-27
PlS Planned sale
140 -0.6%
334.39
US$46,815 		140 -0.6% 334.39 US$46,815
2026-03-02 2026-02-27
PlS Planned sale
942 -4.1%
332.48
US$313,196 		942 -4.1% 332.48 US$313,196
2026-03-02 2026-02-27
PlS Planned sale
1,159 -4.8%
331.49
US$384,197 		1,159 -4.8% 331.49 US$384,197
2026-03-02 2026-02-27
PlS Planned sale
2,259 -8.5%
330.73
US$747,119 		2,259 -8.5% 330.73 US$747,119
2026-03-02 2026-02-27
PlS Planned sale
127 -0.5%
328.92
US$41,773 		127 -0.5% 328.92 US$41,773
2026-02-27 2026-02-27
PrS Proposed sale
4,627
331.34
US$1,533,107 		4,627 331.34 US$1,533,107
2026-02-17 2026-02-13
S Sale
2,242 -8.3%
310.08
US$695,201 		2,242 -8.3% 310.08 US$695,201
2026-01-14 2026-01-12
S Sale
15 -0.1%
377.82
US$5,667 		15 -0.1% 377.82 US$5,667
2026-01-14 2026-01-12
S Sale
19 -0.1%
375.65
US$7,137 		19 -0.1% 375.65 US$7,137
2026-01-14 2026-01-12
S Sale
14 -0.1%
374.44
US$5,242 		14 -0.1% 374.44 US$5,242
2026-01-14 2026-01-12
S Sale
3 -0.0%
372.46
US$1,117 		3 -0.0% 372.46 US$1,117
2026-01-14 2026-01-12
S Sale
18 -0.1%
370.87
US$6,676 		18 -0.1% 370.87 US$6,676
2026-01-14 2026-01-12
S Sale
40 -0.2%
369.48
US$14,779 		40 -0.2% 369.48 US$14,779
2026-01-14 2026-01-12
S Sale
92 -0.4%
368.62
US$33,913 		92 -0.4% 368.62 US$33,913
2026-01-14 2026-01-12
S Sale
41 -0.2%
367.40
US$15,063 		41 -0.2% 367.40 US$15,063
2026-01-14 2026-01-12
S Sale
50 -0.2%
366.41
US$18,320 		50 -0.2% 366.41 US$18,320
2026-01-14 2026-01-12
S Sale
220 -1.0%
365.56
US$80,423 		220 -1.0% 365.56 US$80,423